Cannabis Co. Cresco Lab's Q2 Gross Profit Increases Over 9% YoY, Reports Nearly 7% Drop In Revenue

Zinger Key Points
  • Cresco Labs' net revenues totaled $184.3 million in Q2, down from $197.9 million in the prior year’s period.
  • Gross profit totaled $94.8 million in Q2, up from $86.7 million in the same period last year.

Cannabis producer and operator of Sunnyside dispensaries, Cresco Labs Inc. CL CRLBF 6CQ released its financial and operating results Thursday for the second quarter ended June 30, 2024.

"Our Q2 results demonstrate the sustainability of the improvements we've made to the business over the past year with $184 million in revenue at a 29% Adjusted EBITDA margin," said CEO Charles Bachtell. "It is clear our strategy is working; we are creating the brands consumers love and delivering best-in-class retail operations through Sunnyside."

Read Also: Paying Dues For Nothing? Cannabis Workers At Cresco Labs’ Illinois Facility Leave The Union, Get 15% Raises

Q2 2024 Financial Highlights

  • Net revenues totaled $184.3 million, down from $197.9 million in the prior year's period.
  • Gross profit totaled $94.8 million, up from $86.7 million in the same period last year.
  • Gross profit margin was 51.4%, up from 43.8% in the second quarter of fiscal 2023.
  • Operating income was $32.4 million, compared to a $10.7 million loss from operations in the same period of fiscal 2024.
  • Net loss totaled $51.2 million, up from $43.5 million net loss in the prior year's period.
  • Adjusted EBITDA (a non-GAAP measure) came in positive at $53.9 million, compared to an adjusted EBITDA gain of $40.5 million in the corresponding quarter of last year.
  • Second quarter operating cash flow of $17 million and free cash flow of $11 million.

The company continues to hold the No. 1 share position in Illinois, Pennsylvania and Massachusetts.

"So far this year we've generated over twice as much operating cash flow than the first half of last year and we are putting it to work strengthening our balance sheet, investing in our core growth states with adult-use optionality, and exploring accretive, incremental M&A and other business opportunities," Bachtell continued.

Read Next:

CRLBF Price Action

Cresco's shares traded 2.80% higher at $1.48 per share at the time of publishing late morning on Thursday.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsCannabis EarningsCCCCharles Bachtellfinancial resultssecond quarter earningsSunnyside cannabis
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.